Intra-Cellular Therapies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.

Top 25 shareholders own 68.53% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.5%	FMR LLC	11,116,229	R$5.5b	-1.03%	0.05%
9.08%	The Vanguard Group, Inc.	9,628,253	R$4.8b	0.22%	0.01%
5.87%	BlackRock, Inc.	6,219,077	R$3.1b	-1.62%	0.01%
4.87%	JP Morgan Asset Management	5,165,365	R$2.6b	52.1%	0.05%
4.47%	Alafi Capital Company LLC	4,743,770	R$2.4b	0%	100.0%
3.63%	Wasatch Advisors LP	3,848,588	R$1.9b	3.51%	1.09%
2.88%	Avoro Capital Advisors LLC	3,050,000	R$1.5b	1.67%	3.5%
2.8%	Invesco Ltd.	2,965,239	R$1.5b	5.47%	0.07%
2.34%	Bellevue Asset Management AG	2,485,627	R$1.2b	0.58%	2.51%
1.83%	Norges Bank Investment Management	1,943,730	R$968.0m	0%	0.01%
1.75%	State Street Global Advisors, Inc.	1,858,915	R$925.8m	3.14%	0.01%
1.63%	ClearBridge Investments, LLC	1,729,729	R$861.5m	0.47%	0.11%
1.61%	Geode Capital Management, LLC	1,708,301	R$850.8m	1.31%	0.01%
1.53%	Perceptive Advisors LLC	1,622,215	R$807.9m	-5.49%	3.0%
1.53%	Pictet Asset Management Limited	1,619,268	R$806.4m	29%	0.12%
1.51%	Deep Track Capital, LP	1,600,693	R$797.2m	4.08%	4.12%
1.42%	Franklin Resources, Inc.	1,507,506	R$750.8m	8.53%	0.04%
1.36%	Suvretta Capital Management, LLC	1,439,026	R$716.7m	-8.11%	4.41%
1.32%	GW&K Investment Management, LLC	1,394,196	R$694.4m	0.02%	0.93%
1.29%	Holocene Advisors, LP	1,370,831	R$682.7m	-7.36%	0.45%
1.14%	AllianceBernstein L.P.	1,208,338	R$601.8m	-11.6%	0.03%
1.1%	Marshall Wace LLP	1,160,973	R$578.2m	133%	0.14%
1.09%	Westfield Capital Management Company, L.P.	1,159,356	R$577.4m	11.2%	0.41%
1.01%	Sharon Mates	1,070,329	R$533.1m	0%	no data
0.98%	T. Rowe Price Group, Inc.	1,042,455	R$519.2m	-27%	0.01%